HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print May 13, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: jlb.0105005v1 78/2/412    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cruise, M. W. Articles by Hahn, Y. S. Search for Related Content PubMed PubMed Citation Articles by Cruise, M. W. Articles by Hahn, Y. S.

(Journal of Leukocyte Biology. 2005;78:412-425.)
© 2005 by Society for Leukocyte Biology

Increased Fas ligand expression of CD4⁺ T cells by HCV core induces T cell-dependent hepatic inflammation

Michael W. Cruise^*,, Hendrikje M. Melief^*, John Lukens^*,, Carolina Soguero^* and Young S. Hahn^*,,,1

^* Beirne Carter Center for Immunology Research and Departments of
Microbiology and
Pathology, University of Virginia, Charlottesville

¹ Correspondence: Department of Microbiology and Beirne Carter Center, University of Virginia, HSC Box 801386, Charlottesville, VA 22908. E-mail: ysh5e{at}virginia.edu

Hepatitis C virus (HCV) infection is associated with a high rate of viral persistence and the development of chronic liver disease. The expression of HCV core protein in T cells has previously been reported to alter T cell activation and has been linked to the development of liver inflammation. However, the molecular and cellular basis for the role of HCV core-expressing T cells in liver inflammation is not understood. Here, using double-transgenic mice of CD2/HCV-core transgenic mice and ovalbumin (OVA)-specific T cell receptor transgenic mice, we demonstrated that in vivo antigenic stimulation (OVA peptide administration) triggers a marked influx of core-expressing, antigen-specific, transgenic CD4⁺ T cells into the liver of these mice. Phenotypic analysis of the liver-infiltrating T cells revealed high expression levels of CD44 and Fas ligand (FasL). Adoptive transfer of liver-infiltrating, core-expressing CD4⁺ T cells into severe combined immunodeficiency mice directly demonstrated the capacity of these activated T cells to induce liver inflammation. It is important that anti-FasL antibody treatment of the mice at the time of cell transfer abrogated the liver inflammation induced by core-expressing CD4⁺ T cells. These findings suggest that activated T lymphocytes expressing elevated levels of FasL may be involved in the bystander killing of hepatocyte, as well as the induction of chronic liver inflammation, by promoting recruitment of proinflammatory cells to the liver.

Key Words: intrahepatic lymphocytes • FasL

This article has been cited by other articles:

				S. L. Sheasley-O'Neill, C. C. Brinkman, A. R. Ferguson, M. C. Dispenza, and V. H. Engelhard Dendritic Cell Immunization Route Determines Integrin Expression and Lymphoid and Nonlymphoid Tissue Distribution of CD8 T Cells J. Immunol., February 1, 2007; 178(3): 1512 - 1522. [Abstract] [Full Text] [PDF]

				M. W. Cruise, J. R. Lukens, A. P. Nguyen, M. G. Lassen, S. N. Waggoner, and Y. S. Hahn Fas Ligand Is Responsible for CXCR3 Chemokine Induction in CD4+ T Cell-Dependent Liver Damage J. Immunol., May 15, 2006; 176(10): 6235 - 6244. [Abstract] [Full Text] [PDF]